RTSL Stock Price, Chart, Stats & News

Rapid Therapeutic Science Laboratories, Inc.
Save
Rapid Therapeutic Science Laboratories, Inc. (RTSL) does not currently pay a dividend.
3,533
Market cap
0.04x
Current P/E
–
Forward P/E
RTSL chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices.
Similar securities
Based on sector and market capitalization
Report issue





